the benefits of glp-1 drugs beyond obesity and health: weight loss in Ozempic era GLP-1 Agonists: Using Semaglutide, Tirzepatide,

doi: 10.1016/j.phrs.2022.106448

( a ) Representative dose-response curves of cAMP assays with GIP (agonist mode) and AMG 133 or hGIPR-Ab/P1 + 50 pM GIP (antagonist mode) in cells expressing human GIPR

In Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs, Dr

While semaglutide does not directly increase estrogen, the weight loss it produces can reduce excess aromatase activity and normalize estrogen ratios, particularly in women who are carrying excess visceral fat

As patients lose substantial weight, their metabolic demands change, potentially altering the dose of levothyroxine needed to maintain euthyroid status

[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Ludvik B, Fras JP, Tinahones FJ, et al